Apixaban, an oral direct factor Xa inhibitor: multiple-dose safety, pharacokinetics, and pharmacodynamics in healthy subjects [abstract no PM-664]. Prestented at ISTH 2007
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.